11.34 USD
↘ 0.29 (2.49%)AT CLOSE (03:59 PM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
11.33
↘ 0.01 (0.09%)
POST MARKET (AS OF 05:33 PM EDT)
Post Market
AS OF 05:33 PM EDT
11.33
↘ 0.01 (0.09%)
Market: OPEN
SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $11.33 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 6, 2026.
Open?$11.63
High?$11.67
Low?$11.11
Prev. Close?$11.63
Volume?4.0M
Avg. Volume?6.7M
VWAP?$11.36
Rel. Volume?0.59x
Bid / Ask
Bid?$9.71 × 100
Ask?$12.96 × 100
Spread?$3.25
Midpoint?$11.34
Valuation & Ratios
Market Cap?2.3B
Shares Out?201.9M
Float?199.3M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?17.06
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Themes
Employees
13
Market Cap
2.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?179.89Safe
Confidence?52%Low
Short InterestSqueeze Risk
Short % of Float?29.64%Squeeze Risk
Short Interest?59.1M
Days to Cover?8.6
Free Float199.3M
Avg Daily Volume6.9M
Settlement Date2026-09-15
Financial Health
Current Ratio?18.83Strong
Quick Ratio?18.83Strong
Cash Ratio?18.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?17.06HIGH▾
Peers100
S&P9
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-62.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.6%WEAK▾
S&P7
ROA?-22.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28423000
Enterprise Value?$2.2B
Fundamentals ratios updated end of day